Dr. Jay Battacharya, a Stanford University physician and economist is uniquely positioned to have a balanced and informed perspective on coronavirus and the extreme lockdown of the economy. He makes many of the same points that I have been trying to make in my posts, but is much more knowledgeable and articulate. He wrote an editorial in the Wall Street Journal, (WSJ Comm.) and here is a great interview he has given (interview). Please watch and please share as widely as you can. Please note that he particularly emphasizes the need to get this random population sampling done, which should be both antibody and infection testing, so that we have better information about what the real infection rate and mortality rate of coronavirus are. And he also strongly emphasizes that on the other side of the balance scale, the economic lockdown and resulting depression will cost millions of lives.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Masking Kids Was Futile and Damaging
February 7, 2025
Masking Kids Was Futile and Damaging
The evidence clearly shows that masking children made no difference in CV-19 infection rates.
Commentary
The First Trump Era Jobs Report
February 7, 2025
The First Trump Era Jobs Report
Incorporating major population and job revisions, the report on January jobs is about as expected.
Commentary
No Need for More CV-19 Vax Doses
February 5, 2025
No Need for More CV-19 Vax Doses
Studies continue to show essentially no benefit from additional doses of CV-19 vax.